Evidence map›Paper›PMID 31391319›Full record

Trial reportScience translational medicine2019

Intranasal micro-optical coherence tomography imaging for cystic fibrosis studies.

Hui Min Leung, Susan E Birket, Chulho Hyun, Timothy N Ford, Dongyao Cui, George M Solomon, Ren-Jay Shei, Adegboyega Timothy Adewale, Andrew R Lenzie, Courtney M Fernandez-Petty and 8 more

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Science translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Lipopolysaccharide Causes Acquired CFTR Dysfunction in Murine Nasal Airways.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Article
  7. Optical Imaging of Cilia in the Head and Neck.Journal of clinical medicine · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. IGF-II regulates lysyl oxidase propeptide and mediates its effects in part via basic helix-loop-helix E40.Matrix biology : journal of the International Society for Matrix Biology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Optica · 2023
    Article
  17. Red ginseng aqueous extract improves mucociliary transport dysfunction and histopathology in CF rat airways.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2023
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Hui Min LeungWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA.ORCID 0000-0003-3259-3720
Susan E BirketGregory Fleming James Cystic Fibrosis Research Center, Birmingham, AL 35294, USA.
Chulho HyunWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA.
Timothy N FordWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA.ORCID 0000-0002-1998-9221
Dongyao CuiNanyang Technological University, Singapore 639798, Singapore.
George M SolomonGregory Fleming James Cystic Fibrosis Research Center, Birmingham, AL 35294, USA.ORCID 0000-0002-2969-5518
Ren-Jay SheiGregory Fleming James Cystic Fibrosis Research Center, Birmingham, AL 35294, USA.ORCID 0000-0002-7733-643X
Adegboyega Timothy AdewaleGregory Fleming James Cystic Fibrosis Research Center, Birmingham, AL 35294, USA.ORCID 0000-0002-0471-0515
Andrew R LenzieGregory Fleming James Cystic Fibrosis Research Center, Birmingham, AL 35294, USA.
Courtney M Fernandez-PettyGregory Fleming James Cystic Fibrosis Research Center, Birmingham, AL 35294, USA.
Hui ZhengHarvard Medical School, Boston, MA 02114, USA.
Justin H PalermoWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA.ORCID 0000-0002-3802-1355
Do-Yeon ChoGregory Fleming James Cystic Fibrosis Research Center, Birmingham, AL 35294, USA.ORCID 0000-0002-5173-8959
Bradford A WoodworthGregory Fleming James Cystic Fibrosis Research Center, Birmingham, AL 35294, USA.
Lael M YonkerMucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA 02114, USA.ORCID 0000-0003-1711-8227
Bryan P HurleyMucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA 02114, USA.ORCID 0000-0001-6873-4762
Steven M RoweGregory Fleming James Cystic Fibrosis Research Center, Birmingham, AL 35294, USA. gtearney@partners.org srowe@peds.uab.edu.ORCID 0000-0001-9045-0133
Guillermo J TearneyWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA. gtearney@partners.org srowe@peds.uab.edu.ORCID 0000-0001-8277-4453
Cystic Fibrosis Foundation · USMassachusetts General Hospital · USHarvard University · USNanyang Technological University · SG

Funding

UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI George Martin Solomon · 2007 to 2026
$23.0M
Translational Program in CFTR-Related Airway DiseasesR35HL135816 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROWE, STEVEN MARK · 2017 to 2022
$6.3M
The Role of Hepoxilin A3 in Neutrophil Breach of the Infected Airway MucosaR01AI095338 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HURLEY, BRYAN P · 2012 to 2022
$5.2M
Functional Anatomic Imaging of CF Patients with Early Lung Disease Using microOCTR01HL116213 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROWE, STEVEN MARK, TEARNEY, GUILLERMO J · 2012 to 2015
$2.0M
Functional Categorization of Ciliary Motion in PCDK08HL138153 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SOLOMON, GEORGE MARTIN · 2019 to 2023
$799k
NCATS NIH HHS UL1 TR001417NHLBI NIH HHS K08 HL138153NHLBI NIH HHS R01 HL116213NHLBI NIH HHS R35 HL135816NIAID NIH HHS R01 AI095338NIDDK NIH HHS P30 DK072482
6 · The paper itself

Abstract

Cystic fibrosis (CF) is a genetic disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. Although impairment of mucociliary clearance contributes to severe morbidity and mortality in people with CF, a clear understanding of the pathophysiology is lacking. This is, in part, due to the absence of clinical imaging techniques capable of capturing CFTR-dependent functional metrics at the cellular level. Here, we report the clinical translation of a 1-μm resolution micro-optical coherence tomography (μOCT) technology to quantitatively characterize the functional microanatomy of human upper airways. Using a minimally invasive intranasal imaging approach, we performed a clinical study on age- and sex-matched CF and control groups. We observed delayed mucociliary transport rate at the cellular level, depletion of periciliary liquid layer, and prevalent loss of ciliation in subjects with CF. Distinctive morphological differences in mucus and various forms of epithelial injury were also revealed by μOCT imaging and had prominent effects on the mucociliary transport apparatus. Elevated mucus reflectance intensity in CF, a proxy for viscosity in situ, had a dominant effect. These results demonstrate the utility of μOCT to determine epithelial function and monitor disease status of CF airways on a per-patient basis, with applicability for other diseases of mucus clearance.

Indexed as

Imaging, Three-DimensionalTomography, Optical CoherenceCase-Control StudiesCiliaCystic FibrosisGranulocytesHumansInflammationMucociliary ClearanceMucusNose

Identifiers

PMID31391319
PMCPMC6886258
OpenAlexW2965263373

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.